Hybrid based SVM model for prediction of CDKs and cyclins

The cyclin-dependent kinases (Cdks) are a family of serine/threonine protein kinases whose members are small proteins (∼34–40 kDa) composed of little more than the catalytic core shared by all protein kinases. All Cdks share the feature that their enzymatic activation requires the binding of a regulatory cyclin subunit. Various combination of both cyclin dependent kinases (CDKs) and cyclin proteins are responsible for progression of cell cycle through various phases like G1, S, G2 and M.. CDKs are also essential for proliferation of specialized cells. Realizing the importance of both these proteins in various aspects of life a new efficient computational model has been developed using parameters like hybrid composition for prediction of these proteins. In order to improve the prediction accuracy, we have developed a hybrid module using all features of a protein, which consisted of amino acid composition, dipeptide and pseudo amino acid composition and resulted in an input vector of 450 dimensions (400 dipeptide compositions, 30 pseudo, 20 amino acid compositions of the protein ). The overall prediction accuracy of SVM modules based on dipeptide composition, amino acid and pseudo composition hybrid approach was 99.7914% respectively. The accuracy of all the modules was evaluated using a 10-fold cross-validation technique.

[1]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[2]  Dinesh Gupta,et al.  CyclinPred: A SVM-Based Method for Predicting Cyclin Protein Sequences , 2008, PloS one.

[3]  Peter M Fischer,et al.  Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology. , 2008, Trends in pharmacological sciences.

[4]  Hiroyuki Goto,et al.  Efficient Scheduling Focusing on the Duality of MPL Representation , 2007, 2007 IEEE Symposium on Computational Intelligence in Scheduling.

[5]  Christopher Haslett,et al.  Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis , 2006, Nature Medicine.

[6]  R. Misra,et al.  Clinical progress of selective cyclin-dependent kinase (CDK) inhibitors , 2006 .

[7]  R. Poon,et al.  A roller coaster ride with the mitotic cyclins. , 2005, Seminars in cell & developmental biology.

[8]  S. Zielinski,et al.  International Court of Justice , 2002, International Organization.

[9]  Umberto Galderisi,et al.  Cell cycle regulation and neural differentiation , 2003, Oncogene.

[10]  Zhirong Sun,et al.  Support vector machine approach for protein subcellular localization prediction , 2001, Bioinform..

[11]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[12]  D. Donoghue,et al.  Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin–cyclin interaction , 2000, The EMBO journal.

[13]  Vladimir N. Vapnik,et al.  The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.

[14]  G. Karp Cell and molecular biology : concepts and experiments / Gerald Karp , 1996 .

[15]  E. Nigg,et al.  Cyclin‐dependent protein kinases: Key regulators of the eukaryotic cell cycle , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[16]  S. Elledge,et al.  Human cyclin F. , 1994, The EMBO journal.